BrainStorm Cell Therapeutics Inc. (BCLI) Reports Q3 2026 Results; No Figures Provided
BrainStorm Cell Therapeutics announced financial results for the quarter ended September 30, 2026, but the release provides no financial figures. It said preparations continue for the Phase 3b ENDURANCE study of NurOwn in ALS.Material DetailsContext by AI AnalystThe update places BrainStorm in clin…